MIR155HG and cervical carcinoma: MIR155HG was shown to be significantly upregulated in cervical cancer patients, and propofol reduced the expression of MIR155HG, thereby inhibiting the growth and invasion of cervical cancer cells, and this effect was confirmed both in vivo and in vitro (Du et al., 2021).